EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Managing Alpha‐Gal Allergy in a Case of Bioprosthetic TAVR

Ruchi Patel iD, Aarav Patel iD, Ruchi Biswas, Benjamin Hsieh, Dhanasekaran Ramasamy, Chirag Patel

Case Reports in Immunology · 2026-01 · 2026 (1)

DOI: 10.1155/crii/8190714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Immunology, online erschienen am 24.04.2026. Verfasst von Ruchi Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA, rutgers.edu. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha‐gal syndrome (AGS) is an uncommon IgE‐mediated allergy to mammalian‐derived products, caused by sensitization to the oligosaccharide galactose‐α‐1,3‐galactose (alpha‐gal) after tick exposure. Although AGS is best recognized for delayed anaphylaxis following ingestion of red meat, its implications for exposure to mammalian‐derived biomaterials remain poorly characterized. We present an elderly woman with AGS who required transcatheter aortic valve replacement (TAVR) using a bovine bioprosthesis. An 84‐year‐old woman with serologically confirmed AGS following a Lone Star tick bite in 2012 presented with symptomatic severe aortic stenosis. Her clinical history included multiple allergic reactions to beef, persistently elevated IgE to beef, pork, and lamb, and a specific alpha‐gal IgE >100 kU/L. Following a multidisciplinary evaluation, she was not considered a candidate for a mechanical valve. A prophylactic regimen was implemented, including cetirizine, omalizumab, and 60 mg prednisone 6 h prior to TAVR. The procedure was successfully performed with a bovine‐derived bioprosthetic valve. Perioperative tryptase levels remained within normal range (5.2 µg/L), and no hypersensitivity reactions occurred. Postoperatively, prednisone was tapered, while fexofenadine and omalizumab were continued for 6 months. This case highlights that bioprosthetic valve replacement can be safely performed in AGS patients through multidisciplinary planning and individualized prophylaxis strategies. Further data are needed to develop standardized perioperative management protocols for this rare but clinically significant condition.

Schlagwörter

Stichwörter der Autor:innen

TAVRalpha-gal syndromeanaphylaxisbioprosthetic valvehypersensitivityomalizumab

Autor:innen und Institutionen

  • Department of Medicine, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA, rutgers.edu.
  • Somerset County Vocational and Technical High School, Bridgewater, New Jersey, USA.
  • Private Practice, Allied Digestive Health, Union, New Jersey, USA.
  • Private Practice, Ocean Allergy, Brick, New Jersey, USA.

ORCID-Profile: Ruchi Patel, Aarav Patel

Zitieren

APA

Patel, R., Patel, A., Biswas, R., Hsieh, B., Ramasamy, D., & Patel, C. (2026). Managing Alpha‐Gal Allergy in a Case of Bioprosthetic TAVR. Case Reports in Immunology, 2026(1). https://doi.org/10.1155/crii/8190714

Vancouver

Patel R, Patel A, Biswas R, Hsieh B, Ramasamy D, Patel C. Managing Alpha‐Gal Allergy in a Case of Bioprosthetic TAVR. Case Reports in Immunology. 2026;2026(1). doi:10.1155/crii/8190714

BibTeX
@article{Patel2026,
  author = {Patel, Ruchi and Patel, Aarav and Biswas, Ruchi and Hsieh, Benjamin and Ramasamy, Dhanasekaran and Patel, Chirag},
  title = {Managing Alpha‐Gal Allergy in a Case of Bioprosthetic TAVR},
  journal = {Case Reports in Immunology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crii/8190714}
}
Kostenlos starten →